CYPHERPUNK TECHNOLOGIES INC. Shares Issued
CYPHERPUNK TECHNOLOGIES INC. (CYPH) had Shares Issued of 107.76 million shares as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-12
- 2026-06-30: Common Stock, Shares, Issued 107.76M shares.
- 2026-03-31: Common Stock, Shares, Issued 93.93M shares.
- 2025-12-31: Common Stock, Shares, Issued 83.85M shares.
- 2025-09-30: Common Stock, Shares, Issued 41.44M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 107.76M shares 10-Q · filed 2026-08-12 | |
| 2026-03-31 | 93.93M shares 10-Q · filed 2026-05-14 | |
| 2025-12-31 | 83.85M shares 10-Q · filed 2026-08-12 | |
| 2025-09-30 | 41.44M shares 10-Q · filed 2025-11-12 | |
| 2025-06-30 | 41.44M shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 41.44M shares 10-Q · filed 2025-05-13 | |
| 2024-12-31 | 38.33M shares 10-K · filed 2026-03-16 | |
| 2024-09-30 | 38.26M shares 10-Q · filed 2024-11-13 | |
| 2024-06-30 | 38.26M shares 10-Q · filed 2024-08-12 | |
| 2024-03-31 | 25.60M shares 10-Q · filed 2024-05-13 | |
| 2023-12-31 | 25.57M shares 10-K · filed 2025-03-26 | |
| 2023-09-30 | 25.57M shares 10-Q · filed 2023-11-13 | |
| 2023-06-30 | 25.57M shares 10-Q · filed 2023-08-14 | |
| 2023-03-31 | 119.41M shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 9.90M shares 10-K · filed 2024-03-18 | 99.02M shares 10-K · filed 2023-03-24 |
| 2022-09-30 | 99.02M shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 88.32M shares 10-Q · filed 2022-08-12 | |
| 2022-03-31 | 88.32M shares 10-Q · filed 2022-05-13 | |
| 2021-12-31 | 88.32M shares 10-K · filed 2023-03-24 | |
| 2021-09-30 | 87.84M shares 10-Q · filed 2021-11-12 | |
| 2021-06-30 | 59.67M shares 10-Q · filed 2021-08-13 | |
| 2021-03-31 | 59.67M shares 10-Q · filed 2021-05-14 | |
| 2020-12-31 | 59.66M shares 10-K · filed 2022-03-11 | |
| 2020-09-30 | 59.66M shares 10-Q · filed 2020-11-12 | |
| 2020-06-30 | 59.66M shares 10-Q · filed 2020-08-13 | |
| 2020-03-31 | 35.80M shares 10-Q · filed 2020-05-14 | |
| 2019-12-31 | 24.19M shares 10-K · filed 2021-03-12 | |
| 2019-09-30 | 24.19M shares 10-Q · filed 2019-11-14 | |
| 2019-06-30 | 22.95M shares 10-Q · filed 2019-08-09 | |
| 2019-03-31 | 22.26M shares 10-Q · filed 2019-05-15 | |
| 2018-12-31 | 14.70M shares 10-K · filed 2020-03-16 | |
| 2018-09-30 | 14.70M shares 10-Q · filed 2018-11-09 | |
| 2018-06-30 | 14.70M shares 10-Q · filed 2018-08-08 | |
| 2018-03-31 | 14.50M shares 10-Q/A · filed 2018-08-08 | |
| 2017-12-31 | 12.35M shares 10-K · filed 2019-04-01 | |
| 2016-12-31 | 0.00 shares 10-K · filed 2018-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |